[2] Another peptide, Ipamorelin, is similar to GHRP but often preferred for its milder effects
A narrative review of clinical studies
Key Takeaways 24.2% weight loss at 48 weeks with 12mg dose, the highest efficacy seen in any GLP-1 class medication trial 93% of participants on 12mg achieved 15% weight loss
Strength increases become apparent within the first week of use
First Week: Initial Adjustment Most patients start experiencing appetite changes within the first week of treatment
The agency proposed excluding semaglutide, tirzepatide, and liraglutide the active ingredients in popular GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro from the list of drugs that large-scale compounding pharmacies can produce